Now showing items 1-2 of 2
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
(Lausanne : Frontiers Media, 2022)
Royleanone Derivatives From Plectranthus spp. as a Novel Class of P-Glycoprotein Inhibitors
(Lausanne : Frontiers, 2020)